A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis
Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Efrat Kochba(Israel Institute for Biological Research), Yotam Levin, Tak Mao Chan(Chinese University of Hong Kong), Man‐Fung Yuen(University of Hong Kong - Shenzhen Hospital), Sydney Tang(Chinese University of Hong Kong), Sing‐Leung Lui(Tung Wah Hospital), Kwok‐Hung Chan(University of Hong Kong), Johnson Yiu‐Nam Lau(Hong Kong Baptist University), Terence Yip(Tung Wah Hospital), Desmond Yat‐Hin Yap(Chinese University of Hong Kong), Ruiqi Zhang(University of Hong Kong)
Cited by 27
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k